Immune Responses against Disseminated Tumor Cells
Most cancer-related deaths are a consequence of metastases, a series of linear events, notably the invasion–metastasis cascade. The current understanding of cancer immune surveillance derives from studies in primary tumors, but disseminated cancer cells acquire mutations and, in some cases, appear t...
Main Authors: | Ling Peng, Yongchang Zhang, Zibing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2515 |
Similar Items
-
Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer
by: Hao-fan Wang, et al.
Published: (2019-06-01) -
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
by: Matteo Donadon, et al.
Published: (2018-05-01) -
Immune Checkpoint Blockade – How Does It Work in Brain Metastases?
by: Mihaela Lorger, et al.
Published: (2019-11-01) -
The Aryl Hydrocarbon Receptor and Tumor Immunity
by: Ping Xue, et al.
Published: (2018-02-01) -
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
by: Liu Zhenjiang, et al.
Published: (2017-09-01)